[go: up one dir, main page]

TR199900505T2 - - Google Patents

Info

Publication number
TR199900505T2
TR199900505T2 TR1999/00505T TR9900505T TR199900505T2 TR 199900505 T2 TR199900505 T2 TR 199900505T2 TR 1999/00505 T TR1999/00505 T TR 1999/00505T TR 9900505 T TR9900505 T TR 9900505T TR 199900505 T2 TR199900505 T2 TR 199900505T2
Authority
TR
Turkey
Prior art keywords
prophylaxis
formulation
treatment
controlled release
certain disorders
Prior art date
Application number
TR1999/00505T
Other languages
English (en)
Turkish (tr)
Inventor
Marie Milosovich Susan
Muldoon William
Albert Napper James
Rousseau Laurence
Sauer Joseph
Original Assignee
Smithkline Beecham P.L.C.
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C., Smithkline Beecham Corporation filed Critical Smithkline Beecham P.L.C.
Publication of TR199900505T2 publication Critical patent/TR199900505T2/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
TR1999/00505T 1996-09-12 1997-09-08 TR199900505T2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9619074.9A GB9619074D0 (en) 1996-09-12 1996-09-12 Composition

Publications (1)

Publication Number Publication Date
TR199900505T2 true TR199900505T2 (es) 1999-06-21

Family

ID=10799833

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/00505T TR199900505T2 (es) 1996-09-12 1997-09-08

Country Status (22)

Country Link
EP (1) EP0929301A2 (es)
JP (1) JP2001500150A (es)
KR (1) KR20000036039A (es)
CN (2) CN1235544A (es)
AR (1) AR008176A1 (es)
AU (1) AU724086B2 (es)
BR (1) BR9711734A (es)
CA (1) CA2265661A1 (es)
CO (1) CO5031291A1 (es)
CZ (1) CZ83299A3 (es)
GB (1) GB9619074D0 (es)
HU (1) HUP9904401A3 (es)
ID (1) ID19589A (es)
IL (1) IL128781A0 (es)
MA (1) MA24359A1 (es)
NO (1) NO991194L (es)
NZ (1) NZ334268A (es)
PE (1) PE2499A1 (es)
PL (1) PL332074A1 (es)
TR (1) TR199900505T2 (es)
WO (1) WO1998010762A2 (es)
ZA (1) ZA978133B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2775597B1 (fr) * 1998-03-04 2001-04-20 Gattefosse Ets Sa Pellet administrable par voie orale apte a ameliorer la biodisponibilite de la substance active, procede de fabrication
KR20010034588A (ko) * 1998-03-11 2001-04-25 피터 기딩스 조성물
DE19918325A1 (de) * 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
FR2796840B1 (fr) * 1999-07-26 2003-06-20 Ethypharm Lab Prod Ethiques Comprimes faiblement doses et procede de preparation
US6733781B2 (en) * 2000-12-06 2004-05-11 Wyeth Fast dissolving tablet
MY142204A (en) 2002-07-25 2010-10-29 Pharmacia Corp Pramipexole once-daily dosage form
US20060252820A1 (en) 2003-04-25 2006-11-09 Tetsuya Suzuki Composition for oral administration containing alkylene dioxybenzene derivative
ATE339192T1 (de) * 2003-05-14 2006-10-15 Eurand Pharmaceuticals Ltd Kontrollierte medikamentfreigabe zusammensetzung mit in vivo mechanikstresswiderstand
US20050142191A1 (en) * 2003-06-23 2005-06-30 Neurochem (International) Limited Pharmaceutical formulations of amyloid inhibiting compounds
JP2005272347A (ja) * 2004-03-24 2005-10-06 Ohara Yakuhin Kogyo Kk 固形製剤の製造方法
KR20070050081A (ko) 2004-08-13 2007-05-14 베링거 인겔하임 인터내셔날 게엠베하 프라미펙솔 또는 약제학적으로 허용되는 이의 염을포함하는 연장 방출형 펠렛 제형, 이의 제조방법 및 이의용도
RS52057B2 (sr) 2004-08-13 2018-03-30 Boehringer Ingelheim Int Formulacija tablete sa produženim oslobađanjem koja sadrži pramipeksol ili njegovu farmaceutski prihvatljivu so
EP1970056A1 (en) * 2007-03-15 2008-09-17 Polichem S.A. Time-specific delayed/pulsatile release dosage forms
US9132096B1 (en) 2014-09-12 2015-09-15 Alkermes Pharma Ireland Limited Abuse resistant pharmaceutical compositions
AU2020257406A1 (en) * 2019-04-19 2021-12-16 Hoffman Technologies Llc Sustained release formulations
WO2026013563A1 (en) 2024-07-09 2026-01-15 Syremis Therapeutics Ltd. New salt forms of sabcomeline
WO2026013566A1 (en) 2024-07-09 2026-01-15 Syremis Therapeutics Ltd. New salt forms of sabcomeline
WO2026013570A1 (en) 2024-07-09 2026-01-15 Syremis Therapeutics Ltd. New salt forms of sabcomeline
WO2026013573A1 (en) 2024-07-09 2026-01-15 Syremis Therapeutics Ltd. New salt forms of sabcomeline
WO2026018155A1 (en) 2024-07-16 2026-01-22 Syremis Therapeutics Ltd. Combinations of sabcomeline with long-acting non-cns penetrant muscarinic antagonists
WO2026018154A1 (en) 2024-07-16 2026-01-22 Syremis Therapeutics Ltd. Combinations of sabcomeline with non-cns penetrant muscarinic antagonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69034146T2 (de) * 1989-04-13 2005-07-14 Beecham Group P.L.C., Brentford Chemische Verbindungen
GB9409718D0 (en) * 1994-05-14 1994-07-06 Smithkline Beecham Plc Novel compounds
GB9421472D0 (en) * 1994-10-25 1994-12-07 Smithkline Beecham Plc Novel methods
AR004178A1 (es) * 1995-07-29 1998-11-04 Smithkline Beecham Plc Procedimiento para la formulacion de un farmaco, una composicion farmaceutica obtenible mediante este procedimiento y el uso de la misma.

Also Published As

Publication number Publication date
JP2001500150A (ja) 2001-01-09
WO1998010762A3 (en) 1998-06-04
ZA978133B (en) 1999-04-12
ID19589A (id) 1998-07-23
WO1998010762A2 (en) 1998-03-19
PE2499A1 (es) 1999-03-24
GB9619074D0 (en) 1996-10-23
PL332074A1 (en) 1999-08-30
CN1235544A (zh) 1999-11-17
EP0929301A2 (en) 1999-07-21
AU724086B2 (en) 2000-09-14
NZ334268A (en) 2000-10-27
CO5031291A1 (es) 2001-04-27
NO991194D0 (no) 1999-03-11
HUP9904401A2 (hu) 2000-06-28
IL128781A0 (en) 2000-01-31
CN1446535A (zh) 2003-10-08
KR20000036039A (ko) 2000-06-26
MA24359A1 (fr) 1998-07-01
AU4128897A (en) 1998-04-02
AR008176A1 (es) 1999-12-09
BR9711734A (pt) 1999-08-24
CA2265661A1 (en) 1998-03-19
NO991194L (no) 1999-03-11
HUP9904401A3 (en) 2001-03-28
CZ83299A3 (cs) 1999-08-11

Similar Documents

Publication Publication Date Title
TR199900505T2 (es)
NO964966L (no) Lactobacillusstammer av human opprinnelse, blandinger samt anvendelse derav
PT1075415E (pt) Arranjo para o controlo dinamico do caimento e adornamento de uma embarcacao
EE9700310A (et) N-propargüül-1-aminoindaani R-enantiomeeri, selle soolade ja kompositsioonide kasutamine
ZA981936B (en) Novel benzimidazole inhibitors of fructose 1,6-bisphosphatase.
ZA200007641B (en) Treatment of airborne allergens.
CY2431B1 (en) Novel phenanthridines substituted in the 6 position.
PT755249E (pt) Utilizacao de inibidores da reaccao de maillard para o tratamento de doenca com base em amiloidose
AP2000001796A0 (en) The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function
IT1285770B1 (it) Composti corticoidei
CA2148988A1 (fr) Utilisation d'extraits de bacteries filamenteuses comme agents cosmetiques contre le vieillissement cutane
IT1306560B1 (it) Dispositivo di regolazione e limitazione della miscela percarburatore.
AU129006S (en) Hitch ball
NO991459D0 (no) Anvendelse av 1-hydroksy-2-pyridoner til behandling av hudinfeksjoner
CA2408541A1 (en) Treating eczema and/or psoriasis
BR0209883A (pt) Uso de inibidores da proteasoma para o tratamento de distúrbios do olho seco
EP0681787A3 (en) Use of an enzyme for the manufacture of an agent suitable for the treatment and / or prophylaxis of coccidiosis.
ES2186807T3 (es) Inhibidores de trombina.
BG100248A (bg) Инхибитори на скваленсинтетаза
EP0938898A3 (en) Treatment of pruritus
DK1133296T3 (da) Ny terapeutisk anvendelse af nicergolin
NO20005548D0 (no) Mykobakterieinhibitorer
TR200002939T2 (tr) Paroksetin maleat
ITMI912466A1 (it) Uso di 1, 2 dipalmitoil-l-alfa-fosfatidil-n, n-dimetiletanolammina, in composizioni dermatologiche
BR9710546A (pt) Formula-Æo para o tratamento e/ou profilaxia de dem-ncia